Authors: Burak, Z Ersoy, O Moretti, JL Erinc, R Ozcan, Z Dirlik, A Sabah, D Basdemir, G

Citation: Z. Burak et al., The role of Tc-99m-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response, EUR J NUCL, 28(9), 2001, pp. 1341-1350

Authors: Ozcan, Z Burak, Z Erinc, R Dirlik, A Basdemir, G Sabah, D Ozkilic, H

Citation: Z. Ozcan et al., Correlation of Tc-99m-sestamibi uptake with blood-pool and osseous phase Tc-99m-MDP uptake in malignant bone and soft-tissue tumours, NUCL MED C, 22(6), 2001, pp. 679-683

Authors: Ozcan, Z Erenel, G Aksoylar, S Kansoy, S Burak, Z Ozkilic, H

Citation: Z. Ozcan et al., False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastoma, CLIN NUCL M, 24(4), 1999, pp. 267-270

Authors: Burak, Z Yuksel, DA Cetingul, N Kantar, M Ozkilic, H Moretti, JL

Citation: Z. Burak et al., The role of Tc-99(m)-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: Comparison with I-131-MIBG and Tc-99(m)-MDP scintigraphy, NUCL MED C, 20(11), 1999, pp. 991-1000

Authors: Ozcan, Z Burak, Z Kumanlioglu, K Sabah, D Basdemir, G Bilkay, B Cetingul, N Ozkilic, H

Citation: Z. Ozcan et al., Assessment of chemotherapy-induced changes in bone sarcomas: Clinical experience with Tc-99(m)-MDP three-phase dynamic bone scintigraphy, NUCL MED C, 20(1), 1999, pp. 41-48